Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target
Schneider, Dussiau, and colleagues show that splenomegaly in myelofibrosis reflects active remodeling of the splenic stromal niche, not only extramedullary hematopoiesis.